Trabedersen (AP 12009) is an antisense oligodeoxynucleotide that specifically inhibits Significantly reduced tumor growth, lymph node metastasis and angiogenesis.
[1]. Luc ValliÈres. Trabedersen, a TGFbeta2-specific antisense oligonucleotide for the treatment of malignant gliomas and other tumors overexpressing TGFbeta2. IDrugs. 2009 Jul;12(7):445-53.
[2]. Karl-Hermann Schlingensiepen, et al. Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer. Cancer Sci. 2011 Jun;102(6):1193-200.
















